How to Evaluate Peptide Quality
Most people buying peptides from research chemical suppliers have no idea what is actually in the vial. Third-party batch testing is the only way to close the quality gap. Here is what serious researchers look for.
Framing: This article is informational -- covering what quality evaluation looks like, not prescribing what you should do. The decision to use any compound rests with you and your physician.
What Is Third-Party Testing?
Third-party testing means an independent analytical laboratory -- one with no financial relationship to the supplier -- analyzes a compound sample and issues a Certificate of Analysis (CoA). The independence is the entire point. A supplier testing their own product has an obvious conflict of interest.
For peptides, third-party testing typically covers two things:
1Identity Verification
Confirms the compound is what it claims to be. Done via mass spectrometry (MS), which measures molecular weight and fragmentation pattern. Without identity verification, a vial labeled "BPC-157" could contain anything.
2Purity Measurement
Measures what percentage of the sample is the target compound. Done via HPLC. The remaining percentage is typically truncated sequences, oxidized variants, or synthesis byproducts. The benchmark: 98%+.
Some labs also test for sterility, endotoxin levels (which cause fever and inflammation), and residual solvents. These are rarer in the research chemical space but standard at pharmaceutical compounding facilities.
Testing Labs in the Peptide Space
Lab reputations evolve. Verify current community standing independently.
Janoshik
Czech Republic
The most widely cited lab in the research chemical peptide space. Batch-specific CoAs are publicly accessible, which allows independent verification -- critical since CoA documents can be fabricated. Their reports have become the de facto community standard.
Colmaric Analyticals
United States
A US-based alternative gaining traction with vendors targeting a US audience. Uses reversed-phase HPLC and LC-MS/MS -- considered rigorous methodology. Good choice for vendors wanting to demonstrate US-anchored quality assurance.
In-House Testing
Vendor-operated
Some suppliers perform their own HPLC or MS testing. The fundamental problem: this is not independent. The same entity producing and testing the compound has an obvious conflict of interest. In-house testing should be treated as supplementary evidence, not primary quality verification.
503A Compounding Pharmacy
United States (licensed)
The highest standard available. Compounding pharmacies operating under 503A must meet USP (United States Pharmacopeia) standards for potency, sterility, and identity -- enforced by state boards of pharmacy and subject to FDA inspection. Currently requires Category 1 classification (pending PCAC review for several peptides).
How to Read a Certificate of Analysis
A CoA is only as useful as your ability to verify and interpret it. Here is what to look for:
In Protocol: Protocol lets you log the batch number for each vial and photograph the label directly in the app -- so you always have a traceable record tied to your dose log. Download free on iOS.
HPLC vs Mass Spectrometry -- What Each Test Actually Does
HPLC
High-Performance Liquid Chromatography
Separates the components of a mixture and measures their relative proportions. The result is a purity percentage -- what fraction of the sample is the target compound vs everything else.
Mass Spectrometry (MS)
MS / LC-MS / LC-MS/MS
Measures the mass-to-charge ratio of ionized molecules, producing a unique fingerprint for each compound. Confirms that the molecular weight and fragmentation pattern match the expected sequence.
Both together is the standard. HPLC without MS cannot rule out a substituted compound. MS without HPLC cannot measure how much of the target compound is present vs impurities.
Red Flags to Watch For
Research Chemical vs Pharmaceutical Compounding: The Quality Gap
The quality difference between a well-sourced research chemical and a compounded pharmaceutical is real, and it is worth understanding precisely.
Research Chemical (Current Market)
- •Third-party testing is voluntary -- good suppliers do it, bad ones do not
- •No sterility testing requirement
- •No endotoxin testing requirement
- •No standardized potency verification
- •No regulatory oversight of production facility
- •Reconstitution environment (your workspace) is uncontrolled
503A Compounding Pharmacy (Category 1)
- •USP standards mandatory for potency, identity, and sterility
- •Sterility testing required for injectable compounds
- •Endotoxin testing required
- •Potency verified by licensed pharmacist
- •FDA-inspectable, state-licensed facility
- •Sterile compounding in ISO-classified cleanroom
The PCAC connection: Several peptides currently restricted from compounding -- including BPC-157, TB-500, and Semax -- are under FDA review on July 23, 2026 for potential Category 1 reclassification. Category 1 would mean these compounds become available through licensed compounding pharmacies with full pharmaceutical standards. Track their status in the Regulatory Registry.
Frequently Asked Questions
What is a Certificate of Analysis (CoA)?
A document from an independent testing lab confirming a compound's identity, purity, and batch number. For peptides: look for the compound name, CAS number, purity (98%+), specific batch/lot number, test date, methodology (HPLC + MS), and a way to verify the report independently.
What is Janoshik and is it reliable?
Janoshik is a Czech Republic laboratory that has become the de facto standard for third-party peptide testing in the research chemical space. They publish CoAs by batch number on their website, enabling independent verification. Always verify directly at janoshik.com -- do not trust a PDF from the supplier alone, since documents can be fabricated.
What purity percentage should peptides be?
98% or higher. Below 98% means a meaningful fraction of the vial is something other than the target compound -- truncated sequences, oxidized variants, or synthesis byproducts. The nature of the impurities typically is not disclosed.
What is the difference between HPLC and mass spectrometry?
HPLC measures purity (what percentage is the target compound). Mass spectrometry confirms identity (is it actually the right molecule). Both are needed. HPLC alone cannot rule out a substituted compound; MS alone cannot measure the purity percentage accurately.
Share this article